Study examines role of biomarkers to evaluate kidney injury in cancer patients

ROCHESTER, Minn. — A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells. “Immune checkpoint inhibitors have…

CO2 laser therapy helps improve sexual function in postmenopausal women with breast cancer

CLEVELAND, Ohio (Feb 3, 2021)–Postmenopausal women often complain of painful intercourse or a lack of desire caused by decreased estrogen levels, which affect vaginal elasticity and lubrication. Survivors of breast cancer typically experience worse symptoms as a result of cancer treatments, and concerns exist regarding hormone therapies. A new study suggests that fractional CO2 laser…

Re:GEN Open, dynamic new peer-reviewed open access journal

New Rochelle, NY, February 3, 2021–Mary Ann Liebert, Inc., publishers and Genetic Engineering & Biotechnology News (GEN) announce the launch of Re:GEN Open, the new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences. Re:GEN Open combines the dynamic, global media presence of GEN with the scientific peer-reviewed publishing expertise…

More than half of cancer survivors have underlying medical conditions associated with severe COVID

ATLANTA – FEBRUARY 3, 2021 – New study finds more than half (56.4%) of cancer survivors in the United States reported having additional underlying medical conditions associated with severe COVID-19 illness. The report appearing in JNCI: The Journal of the National Cancer Institute, suggests that prevalence of these conditions among cancer survivors is nearly 40%…